BARD1 and neoplasm: Since BARD1-FL acts as a tumor suppressor, these studies suggest that the BARD1 they are detecting is likely mutated or a splicing variant, however, more research needs to be conducted to classify the isoforms of BARD1 that play an oncogenic role in HCC.